UBS Group
RPTX

UBS Group’s Repare Therapeutics RPTX Stock Holding History

UBS Group’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,553
Closed -$6.25K – 11073
2025
Q3 		$6.25K Buy
+3,553
New +$5.69K ﹤0.01% 8791
2025
Q2 		– Sell
-32,255
Closed -$31.8K – 10758
2025
Q1 		$31.8K Buy
32,255
+16,952
+111% +$20.4K ﹤0.01% 7900
2024
Q4 		$20K Buy
+15,303
New +$45.6K ﹤0.01% 7867
2024
Q2 		– Sell
-518
Closed -$2.44K – 10006
2024
Q1 		$2.44K Buy
518
+511
+7,300% +$3.27K ﹤0.01% 7901
2023
Q4 		$51 Sell
7
-1,848
-100% -$10.3K ﹤0.01% 8992
2023
Q3 		$22.4K Sell
1,855
-2,789
-60% -$28.8K ﹤0.01% 6744
2023
Q2 		$49.1K Buy
4,644
+2,466
+113% +$25.4K ﹤0.01% 6486
2023
Q1 		$21.4K Sell
2,178
-2,864
-57% -$32.9K ﹤0.01% 7034
2022
Q4 		$74.2K Buy
5,042
+1,491
+42% +$22.3K ﹤0.01% 6379
2022
Q3 		$43K Buy
3,551
+739
+26% +$9.51K ﹤0.01% 6501
2022
Q2 		$39K Sell
2,812
-532
-16% -$6.26K ﹤0.01% 6121
2022
Q1 		$48K Sell
3,344
-2,400
-42% -$35.6K ﹤0.01% 6539
2021
Q4 		$121K Buy
5,744
+2,092
+57% +$49.3K ﹤0.01% 6129
2021
Q3 		$96K Sell
3,652
-2,094
-36% -$67.6K ﹤0.01% 5861
2021
Q2 		$179K Buy
5,746
+4,332
+306% +$142K ﹤0.01% 5439
2021
Q1 		$43K Buy
1,414
+1,214
+607% +$41.2K ﹤0.01% 6703
2020
Q4 		$7K Sell
200
-464
-70% -$13.9K ﹤0.01% 7703
2020
Q3 		$20K Buy
+664
New +$17.6K ﹤0.01% 6315

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group's RPTX Position: Q4 2025 in Review

UBS Group sold out of Repare Therapeutics (RPTX) in Q4 2025, closing a stake of 3,553 shares — an estimated $6.25K sold.

UBS Group first reported a position in RPTX in Q3 2020 and held it in 18 quarters. The position peaked at $179K in Q2 2021. 46 funds tracked by Wall St. Rank hold RPTX as of Q4 2025.

  • UBS Group reported no remaining Repare Therapeutics position as of Q4 2025 after selling out during the quarter.
  • UBS Group sold 3,553 Repare Therapeutics shares in Q4 2025, an estimated $6.25K.
  • UBS Group first reported a position in Repare Therapeutics in Q3 2020 and held it in 18 quarters.
  • UBS Group's Repare Therapeutics position peaked at $179K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Repare Therapeutics as of Q4 2025.

Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.